Baxter International (NYSE: BAX)
Baxter International Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Baxter International Company Info
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
News & Analysis
Why Baxter International Stock Sank by 12% This Week
Macroeconomic woes were taking a toll on the medical tech company.
Why Baxter International Stock Is Sinking Today
Investors were disappointed by the medtech company's Q4 update.
2 Dividend Stocks That Have Raised Their Payouts by 80% in 5 Years
Can these stocks continue hiking their dividend payments?
Why Baxter International Stock Is Tumbling Today
Investors weren't happy with the company's Q2 update.
Got $5,000? These 2 Dividend Stocks Are Near Their 52-Week Lows
These stocks are great places to park your money amid the uncertainty in the markets right now.
Got $5,000? These 3 Solid Dividend Stocks Are Trading Near Their 52-Week Lows
If you're an income investor, these investments should be on your radar right now.
Baxter Beats Q1 Estimates as COVID-19 Boosts Sales
The giant healthcare company saw increased demand in Q1 for several products due to the coronavirus pandemic.
COVID-19 Has U.S. Hospitals Scrambling to Stock Dialysis Supplies
Coronavirus patients in intensive care units are using more dialysis fluids than anyone expected.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.